A critical evaluation of hepatic resection in cirrhosis: optimizing patient selection and outcomes.
Hepatic resection has long been the mainstay of treatment of primary liver cancers, particularly hepatocellular carcinoma (HCC). Because of the high incidence of cirrhosis in patients with HCC, the use of resection was initially limited by the ability of the cirrhotic liver to sustain the surgical insult and the mass reduction. Today, hepatectomy in cirrhosis is undergoing a remarkable evolution. Although surgical and anesthetic improvements have increased the safety of this option, the rapid development of alternative therapies has decreased the need for it. Local excision for small HCC is likely to be replaced by image-guided, percutaneous ablative techniques. Furthermore, total replacement of a cirrhotic liver may be a more effective long-term cure than resection. Unquestionably, resection remains the optimal approach for patients with large tumors and healthy underlying liver function. The role of rapidly evolving new approaches will remain the subject of intensive inquiry in the years to come. In this report, we have attempted to clarify current practice with respect to the evaluation, selection, and technique of resection in cirrhosis, and identify areas of active inquiry.
Emond
Jean C
JC
Center for Liver Disease and Transplantation, College of Physicians and Surgeons of Columbia University, 622 West 168th St., Room PH-14C, New York, NY, USA. jel11@columbia.edu
Samstein
Benjamin
B
Renz
John F
JF
D006528:Carcinoma, Hepatocellular / Q000601:surgery; D015897:Comorbidity; D000075202:Contraindications; D004621:Embolization, Therapeutic; D006498:Hepatectomy; D006801:Humans; D006975:Hypertension, Portal / Q000453:epidemiology; D008103:Liver Cirrhosis / Q000453:epidemiology / Q000601:surgery*; D008111:Liver Function Tests; D008113:Liver Neoplasms / Q000601:surgery; D009364:Neoplasm Recurrence, Local; D018579:Patient Selection; D011169:Portal Vein